Opening book details…
About this Medicine article
6P 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer by H.A. Dar; A. Johansson; A. Nordensköljd; A. Iftimi; C. Yau; G. Perez-Tenorio; C. Benz; B. Nordenskjöld; O. Stål; L. Esserman; T. Fornander; L. Lindström is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- H.A. Dar; A. Johansson; A. Nordensköljd; A. Iftimi; C. Yau; G. Perez-Tenorio; C. Benz; B. Nordenskjöld; O. Stål; L. Esserman; T. Fornander; L. Lindström
- Publisher
- Elsevier BV
- Published
- 2021
- Language
- EN
- Field
- Medicine (Health Sciences)